Regenerative Medicine Market in Japan 2016-2020

Publisher Name :
Date: 28-Sep-2016
No. of pages: 102
Inquire Before Buying

About Regenerative Medicine

Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat damaged or diseased human cells, tissues, or organs. It focuses on repairing, replacing, or regenerating damaged cells, and thus offers a paradigm shift in healthcare treatment. The three main technologies used in regenerative medicine are small molecules and biologics, gene therapy, and cell therapy. Small molecules and biologics help in the regeneration of diseased cells and tissues, whereas cell therapy helps in treating the functioning of existing cells.

This analyst forecast the regenerative medicine market in Japan to grow at a CAGR of 35.3% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the regenerative medicine market in Japan for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various types of regenerative medicine products to end-users like hospitals, ambulatory surgical centers (ASCs), and clinical research laboratories.

The market is divided into the following segments based on product:

Tissue Scaffold

Cell Therapy

The report, Regenerative Medicine Market in Japan 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

CellSeed

JCR Pharmaceuticals

Japan Tissue Engineering

Terumo

Astellas

Caladrius Biosciences

Healios

Fujifilm

Rohto Pharmaceuticals

Other prominent vendors

FUJISOFT Tissue Engineering

MediBIC

MEDI NET

Nikon

TAKARA

CMIC

EPS

Cyfuse Biomedical

Irvine Scientific

Kaken

Regience

Sumitomo Dainippon

Takeda

Alfresa

MEDIPAL Holdings

TOHO

Market driver

Growing partnerships of MNCs with local vendors in Japan

For a full, detailed list, view our report

Market challenge

High cost and failure rate in clinical trials coupled with inadequate clinical evidence

For a full, detailed list, view our report

Market trend

Strong pipeline portfolio of regenerative medicines

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Regenerative Medicine Market in Japan 2016-2020

Table of Contents

PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Healthcare reforms in Japan
PART 06: Regulatory landscape in Japan
ASRM
PMD Act
PART 07: Reimbursement scenario
Reimbursement scenario for regenerative medicine in Japan
PART 08: Gene therapy: An emerging field in regenerative medicine
PART 09: Pipeline portfolio
PART 10: Market landscape
Market overview
Five forces analysis
PART 11: Market segmentation by product
Cell therapy
Cell therapy regenerative medicine market in Japan
Tissue scaffold
Tissue scaffold regenerative medicine market in Japan
PART 12: Market segmentation by application
Dermatology
Musculoskeletal
Cardiovascular
Other
PART 13: Market drivers
Transformation of regulatory landscape fostering quick approval of regenerative medicines
Growing partnerships of MNCs with local vendors in Japan
Recent product approvals fuel the market growth
Government initiatives driving regenerative medicine market in Japan
PART 14: Impact of drivers
PART 15: Market challenges
Ethical challenges involved in regenerative medicine
High cost and failure rate in clinical trials coupled with inadequate clinical evidence
Low competitive edge of Japanese regenerative medicine market over other developed nations
PART 16: Impact of drivers and challenges
PART 17: Market trends
Strong pipeline portfolio of regenerative medicines
Entry of new players expanding the applications of regenerative medicine
Strategic collaborations and acquisitions
Advent of 3D tissue bioprinters for the development of regenerative medicines
PART 18: Vendor landscape
Competitive scenario
Key news
Product approvals
Partnerships
Mergers and acquisitions
Other
PART 19: Key vendor analysis
CellSeed
JCR Pharmaceuticals
Japan Tissue Engineering (J-TEC)
Terumo
Upcoming vendors
Other prominent vendors
PART 20: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Regenerative medicine application in various therapeutics
Exhibit 03: Major applications of regenerative medicine in Japan
Exhibit 04: Regenerative medicine legislation acts in Japan
Exhibit 05: Product approval and regulatory characteristics in Japan
Exhibit 06: Overview of regenerative medicine regulation acts
Exhibit 07: Landscape of regenerative medicine in Japan
Exhibit 08: Risk categories of regenerative medical technologies
Exhibit 09: Regenerative medicine approval process in Japan under the ASRM
Exhibit 10: Regenerative medicine approval process in Japan under PMD Act
Exhibit 11: Comparison of traditional and new product approval process under the PMD Act
Exhibit 12: Conditional approvals for regenerative medical products versus regular approval for pharmaceuticals
Exhibit 13: Japan's NHI pricing methods
Exhibit 14: NHI pricing calculation for TEMCELL HS
Exhibit 15: NHI pricing calculation for HeartSheet A kit
Exhibit 16: NHI pricing calculation for HeartSheet B kit
Exhibit 17: Gene therapy research by sponsorship
Exhibit 18: Regenerative medicine pipeline products in Japan
Exhibit 19: Pipeline analysis of regenerative medicine in Japan 2015
Exhibit 20: Pipeline products of regenerative medicine for cell therapy in 2015
Exhibit 21: Key developments in regenerative medicine market in Japan 2015
Exhibit 22: Regenerative medicine market in Japan 2015-2020 ($ millions)
Exhibit 23: Regenerative medicine market in Japan: Optimistic and pessimistic analyses 2015-2020
Exhibit 24: Optimistic and pessimistic market analysis of regenerative medicine in Japan 2015-2020
Exhibit 25: Five forces analysis
Exhibit 26: Regenerative medicine market in Japan by product 2015 and 2020
Exhibit 27: Positioning of segments (by product type) in regenerative medicine market in Japan 2015
Exhibit 28: Regenerative medicine market in Japan: Lifecycle analysis by product 2015
Exhibit 29: Cell therapy overview
Exhibit 30: Ethical issues involved in different cell therapy research category
Exhibit 31: Stem cell research policies in Japan
Exhibit 32: Key cell therapy products marketed in Japan
Exhibit 33: Cell therapy regenerative medicine market in Japan 2015-2020 ($ millions)
Exhibit 34: Opportunity analysis of cell therapy regenerative medicine market in Japan
Exhibit 35: Collaborations for R&D of tissue scaffold
Exhibit 36: Tissue scaffold regenerative medicine market in Japan 2015-2020 ($ millions)
Exhibit 37: Opportunity analysis of tissue scaffold in Japan regenerative medicine market
Exhibit 38: Regenerative medicine market in Japan by product type 2015-2020 ($ millions)
Exhibit 39: Regenerative medicine market in Japan 2015-2020 (%)
Exhibit 40: Overview of the regenerative medicine dermatology market in Japan
Exhibit 41: Pipeline of regenerative medicine for dermatology
Exhibit 42: Overview of musculoskeletal regenerative medicine market in Japan
Exhibit 43: Overview of cardiovascular regenerative medicine market in Japan
Exhibit 44: Regulatory guidelines in Japan
Exhibit 45: Approval process of SAKIGAKE assignment system
Exhibit 46: Partnerships of MNCs with local vendors in Japan
Exhibit 47: MHLW budget on drug discovery using iPS cells ($ millions)
Exhibit 48: Impact of drivers
Exhibit 49: Force field analysis of regenerative medicine market in Japan
Exhibit 50: Impact of drivers and challenges
Exhibit 51: Regenerative medicine pipeline portfolio 2015
Exhibit 52: Current applications of regenerative medicine
Exhibit 53: Future applications of regenerative medicine
Exhibit 54: Major strategic collaborations and acquisitions in Japan
Exhibit 55: Impact of trends in regenerative medicine in Japan 2015-2020
Exhibit 56: Presence of vendors in regenerative medicine
Exhibit 57: CellSeed: Profile
Exhibit 58: CellSeed: Strength analysis
Exhibit 59: CellSeed: Growth strategy matrix
Exhibit 60: CellSeed: Opportunity assessment
Exhibit 61: JCR Pharmaceuticals: Profile
Exhibit 62: JCR Pharmaceuticals: Strength analysis
Exhibit 63: JCR Pharmaceuticals: Growth strategy matrix
Exhibit 64: JCR Pharmaceuticals: Opportunity assessment
Exhibit 65: J-TEC: Profile
Exhibit 66: J-TEC: Strength analysis
Exhibit 67: J-TEC: Growth strategy matrix
Exhibit 68: J-TEC: Opportunity assessment
Exhibit 69: Terumo: Profile
Exhibit 70: Terumo: Strength analysis
Exhibit 71: Terumo: Growth strategy matrix
Exhibit 72: Terumo: Opportunity assessment
  • Global Tissue Engineering Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 01-Nov-2016        Price: US 3480 Onwards        Pages: 108
    Shower heads is a type of sanitary ware which is widely used in bathroom in our life.Scope of the Report:This report focuses on the Tissue Engineering in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.Market Segment by Manufacturers, this report coversAcelity Integra Lifesciences ......
  • Global Regenerative Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 01-Nov-2016        Price: US 3480 Onwards        Pages: 106
    Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function. It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. An......
  • Global Tissue Engineered Skin Substitutes Market Research Report 2021
    Published: 22-Aug-2016        Price: US 2900 Onwards        Pages: 105
    Notes: Production, means the output of Tissue Engineered Skin Substitutes Revenue, means the sales value of Tissue Engineered Skin Substitutes This report studies Tissue Engineered Skin Substitutes in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Smith & Nephew - Integra - ......
  • Global Regenerative Medicine Market Professional Survey Report 2016
    Published: 19-Aug-2016        Price: US 3500 Onwards        Pages: 115
    Notes: Production, means the output of Regenerative Medicine Revenue, means the sales value of Regenerative Medicine This report studies Regenerative Medicine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, rev......
  • Global Regenerative Medicines Sales Market Report 2021
    Published: 12-Aug-2016        Price: US 4000 Onwards        Pages: 128
    This report studies sales (consumption) of Regenerative Medicines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Celgene Corporation (U.S.) - StemCells, Inc. (U.S.) - Corning Incorporated (U.S.) - Organogenesis Inc. (U.S.) - Acelity (KCI Licensing) (U.S.) - Vertex Pharm......
  • Global Tissue Engineering Sales Market Report 2021
    Published: 12-Aug-2016        Price: US 4000 Onwards        Pages: 128
    This report studies sales (consumption) of Tissue Engineering in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Celgene Corporation (U.S.) - StemCells, Inc. (U.S.) - Corning Incorporated (U.S.) - Organogenesis Inc. (U.S.) - Acelity (KCI Licensing) (U.S.) - Vertex Pharmaceu......
  • United States Regenerative Medicines Sales Market Report 2021
    Published: 03-Aug-2016        Price: US 3800 Onwards        Pages: 122
    This report studies sales (consumption) of Regenerative Medicines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering Celgene Corporation (U.S.) StemCells, Inc. (U.S.) Corning Incorporated (U.S.) Organogenesis Inc. (U.S.) Acelity (KCI Licensing) (U.S.) Vertex Pharmaceuticals Incorporated (U.S.) Split by product types, with sales, revenue, price, market sha......
  • United States Tissue Engineering Sales Market Report 2021
    Published: 03-Aug-2016        Price: US 3800 Onwards        Pages: 121
    This report studies sales (consumption) of Tissue Engineering in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering Celgene Corporation (U.S.) StemCells, Inc. (U.S.) Corning Incorporated (U.S.) Organogenesis Inc. (U.S.) Acelity (KCI Licensing) (U.S.) Vertex Pharmaceuticals Incorporated (U.S.) Split by product types, with sales, revenue, price, market share a......
  • Global Regenerative Medicines Market Research Report 2021
    Published: 27-Jul-2016        Price: US 2900 Onwards        Pages: 126
    This report studies Regenerative Medicines in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering - Celgene Corporation (U.S.) - StemCells, Inc. (U.S.) - Corning Incorporated (U.S.) - Organogenesis Inc. (U.S.) - Acelity (KCI Licensing) (U.S.) - Vertex Pharmaceuticals Incorporated (U.S.) ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs